Canaccord Genuity Group reaffirmed their speculative buy rating on shares of MYCELX Technologies (LON:MYX – Free Report) in a report published on Tuesday morning, Marketbeat Ratings reports. They currently have a GBX 95 ($1.27) target price on the stock.
MYCELX Technologies Price Performance
Shares of MYX stock opened at GBX 38 ($0.51) on Tuesday. The company has a market cap of £9.26 million, a P/E ratio of -316.67 and a beta of 1.00. The company has a debt-to-equity ratio of 12.42, a current ratio of 2.36 and a quick ratio of 2.97. The stock’s 50-day moving average is GBX 52.45 and its 200 day moving average is GBX 54.66. MYCELX Technologies has a 1-year low of GBX 36.25 ($0.49) and a 1-year high of GBX 71.64 ($0.96).
Insider Transactions at MYCELX Technologies
In other news, insider André Schnabl bought 48,836 shares of the firm’s stock in a transaction that occurred on Friday, August 23rd. The stock was bought at an average price of GBX 51 ($0.68) per share, with a total value of £24,906.36 ($33,350.78). Insiders own 19.26% of the company’s stock.
MYCELX Technologies Company Profile
MYCELX Technologies Corporation, a clean water technology company, provides water treatment solutions to the oil and gas, power, marine, and heavy manufacturing sectors in the Middle East, the United States, Nigeria, Australia and internationally. The company offers oil removal solutions for upstream produced water to oil companies; and hydrocarbons removal services from downstream process wastewater that are used in petrochemical facilities and refineries.
Further Reading
- Five stocks we like better than MYCELX Technologies
- Why Invest in 5G? How to Invest in 5G Stocks
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- What is a Special Dividend?
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for MYCELX Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MYCELX Technologies and related companies with MarketBeat.com's FREE daily email newsletter.